These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 7979213)

  • 1. [Cancer of the prostate stage T1. Incidental carcinoma. Review of the literature and an appraisal of the classification].
    Leisinger HJ
    Ann Urol (Paris); 1994; 28(4):229-34. PubMed ID: 7979213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
    Capitanio U; Scattoni V; Freschi M; Briganti A; Salonia A; Gallina A; Colombo R; Karakiewicz PI; Rigatti P; Montorsi F
    Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subclassification of clinical stage T1 prostate cancer: impact on biochemical recurrence following radical prostatectomy.
    Magheli A; Rais-Bahrami S; Carter HB; Peck HJ; Epstein JI; Gonzalgo ML
    J Urol; 2007 Oct; 178(4 Pt 1):1277-80; discussion 1280-1. PubMed ID: 17698121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staging of incidentally detected prostate cancer: role of repeat resection, prostate-specific antigen, needle biopsy, and imaging.
    Griebling TL; Williams RD
    Semin Urol Oncol; 1996 Aug; 14(3):156-64. PubMed ID: 8865478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidental carcinoma of the prostate: histopathology and natural history.
    Nemoto R; Harada M; Uchida K; Koiso K; Abe R; Kato T
    Jpn J Clin Oncol; 1985 Dec; 15(4):619-23. PubMed ID: 2419598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Early diagnosis of cancer of the prostate. Value of systemic screening and of diagnosis in incidental cancer (stage A)].
    Solé Balcells FJ
    Arch Esp Urol; 1989; 42 Suppl 2():131-8. PubMed ID: 2484149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of patients with stage T1b incidental prostate cancer.
    Argyropoulos A; Doumas K; Farmakis A; Aristas O; Kontogeorgos G; Lykourinas M
    Scand J Urol Nephrol; 2005; 39(4):289-93. PubMed ID: 16118104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of prostatic incidental carcinoma].
    Saito K; Takahashi T; Nomura S
    Hinyokika Kiyo; 1989 Aug; 35(8):1347-53. PubMed ID: 2479236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating localized prostate cancer and identifying candidates for focal therapy.
    Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
    Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do clinically insignificant tumors of the prostate exist?
    Stamatiou K; Alevizos A; Mariolis A; Spiliopoulou C; Alevizou A; Bovis K; Sofras F
    Urol Int; 2008; 81(4):379-82. PubMed ID: 19077395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective study of 101 cases with incidental prostate cancer stages T1a and T1b.
    Masue N; Deguchi T; Nakano M; Ehara H; Uno H; Takahashi Y
    Int J Urol; 2005 Dec; 12(12):1045-9. PubMed ID: 16409608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of stage T1a prostate cancer.
    Lowe BA
    Semin Urol Oncol; 1996 Aug; 14(3):178-82. PubMed ID: 8865481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of prostate specific antigen (PSA) and PSA density in the detection of T1a and T1b prostate cancer].
    Meguro N; Maeda O; Saiki S; Kinouchi T; Kuroda M; Usami M; Kotake T
    Hinyokika Kiyo; 1998 Sep; 44(9):639-43. PubMed ID: 9805668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probability of finding T1a and T1b (incidental) prostate cancer during TURP has decreased in the PSA era.
    Jones JS; Follis HW; Johnson JR
    Prostate Cancer Prostatic Dis; 2009; 12(1):57-60. PubMed ID: 18379587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The treatment of locally advanced (T3) prostatic carcinoma using radical prostatectomy or radiotherapy. A review].
    van den Ouden D; Schröder FH
    Tijdschr Gerontol Geriatr; 1998 Apr; 29(2):74-9. PubMed ID: 9615377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of stage a prostatic cancer detected incidentally by transurethral resection of the prostate].
    Nakanishi S; Gotou T; Sawada A; Shibasaki N; Ishitoya T; Okumura K
    Hinyokika Kiyo; 2009 Jan; 55(1):5-8. PubMed ID: 19227204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of DNA ploidy, bcl-2 and p53 in localized prostate adenocarcinoma incidentally discovered at transurethral prostatectomy.
    Abaza R; Diaz LK; Laskin WB; Pins MR
    J Urol; 2006 Dec; 176(6 Pt 1):2701-5. PubMed ID: 17085199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen.
    Obek C; Louis P; Civantos F; Soloway MS
    J Urol; 1999 Feb; 161(2):494-8; discussion 498-9. PubMed ID: 9915434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathology of incidental carcinoma.
    Bostwick DG
    Cancer Surv; 1995; 23():7-18. PubMed ID: 7621475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens.
    Divrik RT; Eroglu A; Sahin A; Zorlu F; Ozen H
    Urol Oncol; 2007; 25(5):376-82. PubMed ID: 17826653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.